What role do intravitreal injections play in the management of retinal vein occlusion, and which patients are most likely to benefit?

The provided UK guideline context does not contain specific information regarding the role of intravitreal injections in the management of retinal vein occlusion or which patients are most likely to benefit from them for this condition.

The guidelines discuss intravitreal anti-VEGFs and steroid implants in the context of managing visual impairment caused by diabetic macular oedema and proliferative diabetic retinopathy ¹. They also cover anti-VEGF therapies for neovascular age-related macular degeneration ²,³.